Clinical Trials List
Protocol NumberGS-US-536-5938
Not yet recruiting
2026-07-01 - 2033-11-30
Phase III
-
Trial Applicant
GILEAD SCIENCES HONG KONG LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 冉浩恩 Division of Infectious Disease
- 薛伶珊 Division of Infectious Disease
- 游天瑜 Division of Infectious Disease
- 蔡文嘉 Division of Infectious Disease
- 羅景霳 Division of Infectious Disease
- 李佳雯 Division of Infectious Disease
- Wen-Chien Ko Division of Infectious Disease
- 李明吉 Division of Infectious Disease
- Po-Lin Chen Division of Infectious Disease
Co-Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
590 participants